Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BioAtla, Inc.
Report date February 28, 2026 · Filed March 02, 2026
Section 16 reporting ended · disclosed 2026-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 343,421 |
Reported balance
After 2026-02-28 transaction · row 1
1 source rowRow 1 · 2026-02-28 · Tax withholding · Disposed 2,729 · Balance 343,421 F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2026 Filed Mar 2, 2026 18:14 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,729 | $0.25 | $674.06 |
DisclosureSEC source: 0001193125-26-085968 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Former Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,421 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2025 Filed Dec 1, 2025 18:37 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,371 | $0.90 | $2,143.38 |
DisclosureSEC source: 0001193125-25-304178 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,150 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP. Read SEC document |
| August 31, 2025 Filed Sep 2, 2025 19:07 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,371 | $0.46 | $1,079.99 |
DisclosureSEC source: 0000950170-25-112614 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,521 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 16:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 2,371 | $0.41 | $969.74 |
DisclosureSEC source: 0000950170-25-080991 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,892 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 16:12 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038745 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,263 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider. Read SEC document |
| February 15, 2025 Filed Feb 24, 2025 20:30 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 10,887 | $0.46 | $5,008.02 |
DisclosureSEC source: 0000950170-25-025967 · ownership.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,263 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 16:22 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantCommon Stock | 106,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003511 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,923 F1 · shares: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on February 15, 2025, and the remainder in equal quarterly installments over the three years thereafter, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 12:26 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $1.47 | $1,425.90 |
DisclosureSEC source: 0001209191-23-054073 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,923 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2023 Filed Oct 2, 2023 18:06 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $1.70 | $1,649.00 |
DisclosureSEC source: 0001209191-23-051184 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,893 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 20:06 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.51 | $2,434.70 |
DisclosureSEC source: 0001209191-23-048035 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,863 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.99 | $2,900.30 |
DisclosureSEC source: 0001209191-23-044051 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,833 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 17:42 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $3.00 | $2,910.00 |
DisclosureSEC source: 0001209191-23-040662 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,780 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:25 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $3.15 | $3,055.50 |
DisclosureSEC source: 0001209191-23-033472 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,750 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2023 Filed May 2, 2023 18:03 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $3.37 | $3,268.90 |
DisclosureSEC source: 0001209191-23-026660 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,720 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:03 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.68 | $2,599.60 |
DisclosureSEC source: 0001209191-23-022430 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,690 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 18:32 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.98 | $2,890.60 |
DisclosureSEC source: 0001209191-23-014292 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,660 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 09, 2023 Filed Mar 1, 2023 18:32 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 210,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001209191-23-014292 · doc4.xml · derivative · entry 2 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2033-02-09 F2 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service to the company through the applicable vesting dates. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 19:10 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,144 | $3.79 | $4,335.76 |
DisclosureSEC source: 0001209191-23-006435 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,630 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 17:06 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $8.25 | $8,002.50 |
DisclosureSEC source: 0001209191-23-000316 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,774 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 21:06 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $11.01 | $10,679.70 |
DisclosureSEC source: 0001209191-22-059269 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,744 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 19:57 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $6.89 | $6,683.30 |
DisclosureSEC source: 0001209191-22-055168 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,714 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 19:47 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $7.70 | $7,469.00 |
DisclosureSEC source: 0001209191-22-052555 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,684 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 18:49 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $8.71 | $8,448.70 |
DisclosureSEC source: 0001209191-22-048364 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,654 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| July 31, 2022 Filed Aug 1, 2022 18:28 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $3.40 | $3,298.00 |
DisclosureSEC source: 0001209191-22-043743 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,624 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 17:25 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.85 | $2,764.50 |
DisclosureSEC source: 0001209191-22-040327 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,594 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 18:05 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $2.41 | $2,337.70 |
DisclosureSEC source: 0001209191-22-034303 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,564 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| April 30, 2022 Filed May 6, 2022 17:01 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $3.48 | $3,375.60 |
DisclosureSEC source: 0001209191-22-027637 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,534 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:15 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $5.00 | $4,850.00 |
DisclosureSEC source: 0001209191-22-022745 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,504 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 28, 2022 Filed Mar 4, 2022 17:07 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 970 | $6.48 | $6,285.60 |
DisclosureSEC source: 0001209191-22-016382 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,474 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| February 21, 2022 Filed Feb 24, 2022 21:18 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 115,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001209191-22-012942 · doc4.xml · derivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2032-02-21 F1 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on February 21, 2023, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:46 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,150 | $9.56 | $10,994.00 |
DisclosureSEC source: 0001209191-22-006504 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,444 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes shares purchased under the Issuer's ESPP Plan. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 20:35 UTC | BioAtla, Inc. BCAB · Entity 879 | Tax withholdingCommon Stock | 1,391 | $19.63 | $27,305.33 |
DisclosureSEC source: 0001209191-22-002043 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,078 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 29 | $22.47 | $651.66 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 8 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,469 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F9 · price: The range of prices for the shares of Common Stock is from $22.40 to $22.51. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,405 | $21.74 | $30,546.11 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 7 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,498 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F8 · price: The range of prices for the shares of Common Stock is from $21.40 to $22.37. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 880 | $24.22 | $21,317.12 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 6 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,903 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F7 · price: The range of prices for the shares of Common Stock is from $23.80 to $24.68. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,034 | $23.27 | $93,855.04 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 5 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,783 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F6 · price: The range of prices for the shares of Common Stock is from $22.79 to $23.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| December 01, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,332 | $22.19 | $51,737.75 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 4 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,817 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F5 · price: The range of prices for the shares of Common Stock is from $21.79 to $22.73. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 848 | $25.38 | $21,521.39 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 3 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,149 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $25.30 to $25.38. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,422 | $24.68 | $59,765.27 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 2 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,997 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $24.33 to $25.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 7, 2021 17:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,240 | $24.00 | $53,753.28 |
DisclosureSEC source: 0001209191-21-068388 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,419 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.33 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 29, 2021 Filed Dec 6, 2021 20:44 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,599 | $23.89 | $109,870.11 |
DisclosureSEC source: 0001209191-21-068218 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,659 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 24, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,124 | $25.77 | $28,966.60 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 6 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,258 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F7 · price: The range of prices for the shares of Common Stock is from $25.57 to $26.14. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 24, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,354 | $25.00 | $33,848.65 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 5 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,382 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F6 · price: The range of prices for the shares of Common Stock is from $24.48 to $25.42. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 24, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,459 | $24.05 | $35,093.33 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 4 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,736 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F5 · price: The range of prices for the shares of Common Stock is from $23.48 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,101 | $26.04 | $54,699.54 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 3 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,195 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $24.85 to $25.70. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 3,669 | $24.29 | $89,101.67 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 2 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,296 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Nov 30, 2021 20:07 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 3,626 | $26.24 | $95,128.11 |
DisclosureSEC source: 0001209191-21-067221 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,965 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 21:29 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 31,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041221 · doc4.xml · nonDerivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,591 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 20:36 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 30,988 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-034353 · doc4.xml · derivative · entry 1 WALDRON RICHARD A · CIK 0001226961 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,988 Underlying: Common Stock · 30,988 shares Expires 2030-12-15 F1 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on December 15, 2021, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.